These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 26679828)
81. PIM-1 kinase inhibitor SMI-4a exerts antitumor effects in chronic myeloid leukemia cells by enhancing the activity of glycogen synthase kinase 3β. Fan RF; Lu Y; Fang ZG; Guo XY; Chen YX; Xu YC; Lei YM; Liu KF; Lin DJ; Liu LL; Liu XF Mol Med Rep; 2017 Oct; 16(4):4603-4612. PubMed ID: 28849186 [TBL] [Abstract][Full Text] [Related]
82. Targeting mitochondrial bioenergetics by combination treatment with imatinib and dichloroacetate in human erythroleukemic K‑562 and colorectal HCT‑116 cancer cells. Kakafika MG; Lyta AA; Gavriilidis GI; Tsiftsoglou SA; Miliotou AN; Pappas IS; Vizirianakis IS; Papadopoulou LC; Tsiftsoglou AS Int J Oncol; 2024 Apr; 64(4):. PubMed ID: 38426621 [TBL] [Abstract][Full Text] [Related]
83. RITA induces apoptosis in p53-null K562 leukemia cells by inhibiting STAT5, Akt, and NF-κB signaling pathways. Mobaraki RN; Karimi M; Alikarami F; Farhadi E; Amini A; Bashash D; Paridar M; Kokhaei P; Rezvani MR; Kazemi A; Safa M Anticancer Drugs; 2018 Oct; 29(9):847-853. PubMed ID: 30157040 [TBL] [Abstract][Full Text] [Related]
84. Peroxisome Proliferator-Activated Receptor Ligands and Their Role in Chronic Myeloid Leukemia: Therapeutic Strategies. Yousefi B; Samadi N; Baradaran B; Shafiei-Irannejad V; Zarghami N Chem Biol Drug Des; 2016 Jul; 88(1):17-25. PubMed ID: 26841308 [TBL] [Abstract][Full Text] [Related]
85. NDRG3 regulates imatinib resistance by promoting β‑catenin accumulation in the nucleus in chronic myelogenous leukemia. Wang X; Rong S; Sun Y; Yin B; Yang X; Lu X; Sun H; Yan Y; Sun G; Liang Y; Wang P; Xie S; Li Y Oncol Rep; 2023 Aug; 50(2):. PubMed ID: 37350410 [TBL] [Abstract][Full Text] [Related]
86. Heme oxygenase-1 contributes to imatinib resistance by promoting autophagy in chronic myeloid leukemia through disrupting the mTOR signaling pathway. Cao L; Wang J; Ma D; Wang P; Zhang Y; Fang Q Biomed Pharmacother; 2016 Mar; 78():30-38. PubMed ID: 26898422 [TBL] [Abstract][Full Text] [Related]
87. Application of ZnO/CNT@Fe Yousefi AM; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Fakhroueian Z; Momeny M; Bashash D Biomed Mater; 2021 Mar; 16(3):. PubMed ID: 33197900 [TBL] [Abstract][Full Text] [Related]
88. Transcriptomic and proteomic approach to studying SNX-2112-induced K562 cells apoptosis and anti-leukemia activity in K562-NOD/SCID mice. Jin L; Xiao CL; Lu CH; Xia M; Xing GW; Xiong S; Liu QY; Liu H; Li YC; Ge F; Wang QD; He QY; Wang YF FEBS Lett; 2009 Jun; 583(12):1859-66. PubMed ID: 19427857 [TBL] [Abstract][Full Text] [Related]
89. Ginkgetin inhibits proliferation of human leukemia cells via the TNF-α signaling pathway. Pan LL; Wu WJ; Zheng GF; Han XY; He JS; Cai Z Z Naturforsch C J Biosci; 2017 Oct; 72(11-12):441-447. PubMed ID: 28902633 [TBL] [Abstract][Full Text] [Related]
90. Knockdown of ADORA2A antisense RNA 1 inhibits cell proliferation and enhances imatinib sensitivity in chronic myeloid leukemia. Liu Y; Li H; Zhao Y; Li D; Zhang Q; Fu J; Fan S Bioengineered; 2022 Feb; 13(2):2296-2307. PubMed ID: 35034552 [TBL] [Abstract][Full Text] [Related]
91. Saponins from Rubus parvifolius L. induce apoptosis in human chronic myeloid leukemia cells through AMPK activation and STAT3 inhibition. Ge YQ; Xu XF; Yang B; Chen Z; Cheng RB Asian Pac J Cancer Prev; 2014; 15(13):5455-61. PubMed ID: 25041018 [TBL] [Abstract][Full Text] [Related]
92. SPHINX-Based Combination Therapy as a Potential Novel Treatment Strategy for Acute Myeloid Leukaemia. Wodi C; Belali T; Morse R; Porazinski S; Ladomery M Br J Biomed Sci; 2023; 80():11041. PubMed ID: 36895328 [No Abstract] [Full Text] [Related]
93. HucMSC exosomes promoted imatinib-induced apoptosis in K562-R cells via a miR-145a-5p/USP6/GLS1 axis. Chen X; Chen Y; Zhang M; Cheng H; Mai H; Yi M; Xu H; Yuan X; Liu S; Wen F Cell Death Dis; 2022 Jan; 13(1):92. PubMed ID: 35091542 [TBL] [Abstract][Full Text] [Related]
94. Growth inhibition and apoptosis in human Philadelphia chromosome-positive lymphoblastic leukemia cell lines by treatment with the dual PPARalpha/gamma ligand TZD18. Liu H; Zang C; Fenner MH; Liu D; Possinger K; Koeffler HP; Elstner E Blood; 2006 May; 107(9):3683-92. PubMed ID: 16403907 [TBL] [Abstract][Full Text] [Related]
95. Single nucleotide polymorphisms in apoptosis pathway are associated with response to imatinib therapy in chronic myeloid leukemia. Zheng Q; Cao J; Hamad N; Kim HJ; Moon JH; Sohn SK; Jung CW; Lipton JH; Kim DD J Transl Med; 2016 Mar; 14():82. PubMed ID: 27009330 [TBL] [Abstract][Full Text] [Related]
96. Rhus verniciflua Stokes extract induces inhibition of cell growth and apoptosis in human chronic myelogenous leukemia K562 cells. Lee KW; Um ES; Jung BB; Choi ES; Kim EY; Lee S; Jang E; Lee JH; Kim Y Oncol Rep; 2018 Mar; 39(3):1141-1147. PubMed ID: 29328387 [TBL] [Abstract][Full Text] [Related]
97. Imatinib mesylate inhibits proliferation and promotes apoptosis of chronic myeloid leukemia cells via STAT3 pathway. Zhang H; Jin X; Diao Y; Wang L; Li N; Chen M Panminerva Med; 2023 Mar; 65(1):118-119. PubMed ID: 31577092 [No Abstract] [Full Text] [Related]
98. CIAPIN1 Targeted NHE1 and ERK1/2 to Suppress NSCLC Cells' Metastasis and Predicted Good Prognosis in NSCLC Patients Receiving Pulmonectomy. Wang J; Zhou Y; Ma L; Cao S; Gao W; Xiong Q; Wang K; Yang L Oxid Med Cell Longev; 2019; 2019():1970818. PubMed ID: 31093311 [TBL] [Abstract][Full Text] [Related]
99. H Paul T; Roy R; Sarkar RD; Sinha S; Biswas N Free Radic Biol Med; 2021 Apr; 166():265-276. PubMed ID: 33631302 [TBL] [Abstract][Full Text] [Related]
100. [Anti-Leukemia Effect and Mechanism of Oridonin on Imatinib-Sensitive and Imatinib-Resistant K562 Cells]. Shan QQ; Guo Y; Gong YP; Lin J; Wang YS Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1378-1383. PubMed ID: 29070111 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]